In vivo imaging technologies have emerged as a powerful tool for both fundamental
research and clinical practice. In particular, luminescence imaging in the tissue-transparent …

In recent years, many promising nanotechnological approaches to biomedical research
have been developed in order to increase implementation of regenerative medicine and …

Cardiovascular diseases (CVD) account for nearly half of all deaths in Europe and almost
30% of global deaths. Despite the improved clinical management, cardiovascular mortality is …

This review focuses on nano-structured delivery devices prepared from biodegradable and
biocompatible natural and synthetic polymers, organic raw materials, metals, metal oxides …

Introduction Magnetic drug targeting utilizes superparamagnetic iron oxide nanoparticles
(SPIONs) to accumulate drugs in specified vasculature regions. Methods We produced …

Almost a third of all fatalities may be attributed to cardiovascular disease (CVD), making it a
primary cause of mortalities worldwide. Better diagnostic tools and secure, non-invasive …

Stent placement is an effective treatment for atherosclerosis, but is suffered from in-stent
restenosis (ISR) caused by stent mechanical damage. Conventional ISR treatment such as …

Once injected into a living organism, cells diffuse or migrate around the initial injection point
and become impossible to be visualized and tracked in vivo. The present work concerns the …

Atherosclerosis is a common form of cardiovascular disease, which is one of the most
prevalent causes of death worldwide, particularly among older individuals. Surgery is the …

Low retention of endothelial progenitor cells (EPCs) in the infarct area has been suggested
to be responsible for the poor clinical efficacy of EPC therapy for myocardial infarction (MI) …